Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1091]
News [2717]
Articles [182]
Editorials [9]
Conferences [110]
elearning [25]

Results of orteronel plus prednisone in the TAK-700 trial on mCRPC

Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA
Results of orteronel plus prednisone in the TAK-700 trial on mCRPC ( Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA )
31 Jan 2014

Results of the MARS study in renal cell carcinoma

Dr Vincent Launay-Vacher - Pitie-Salpetriere Hospital, Paris, France
Results of the MARS study in renal cell carcinoma ( Dr Vincent Launay-Vacher - Pitie-Salpetriere Hospital, Paris, France )
31 Jan 2014

Dissecting the biology of the androgen receptor pathway

Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA
Dissecting the biology of the androgen receptor pathway ( Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA )
30 Jan 2014

The role of molecular biology in the Identification of predictive factors for prostate cancer incidence

Dr José Antonio López - Instituto Valenciano de Oncología, Valencia, Spain
The role of molecular biology in the Identification of predictive factors for prostate cancer incidence ( Dr José Antonio López - Instituto Valenciano de Oncología, Valencia, Spain )
15 Jan 2014

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland )
10 Jan 2014

mCRPC: Challenges and opportunities in a booming area

Dr Nicolas Mottet - University Hospital, Saint-Étienne, France
mCRPC: Challenges and opportunities in a booming area ( Dr Nicolas Mottet - University Hospital, Saint-Étienne, France )
10 Jan 2014

Understanding the biology of the disease to guide treatment choices

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Ireland
Understanding the biology of the disease to guide treatment choices ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Ireland )
10 Jan 2014

Predictors of response to mCRPC therapy: where do we stand?

Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center, Netherlands
Predictors of response to mCRPC therapy: where do we stand? ( Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center, Netherlands )
10 Jan 2014

Managing mCRPC in daily practice: a pragmatic approach

Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK
Managing mCRPC in daily practice: a pragmatic approach ( Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK )
10 Jan 2014

Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion

J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle
Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion ( J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle )
10 Jan 2014

Immunotherapy in metastatic kidney cancer

Dr Thomas Schwabb - Roswell Park Cancer Institute, Buffalo, USA
Immunotherapy in metastatic kidney cancer ( Dr Thomas Schwabb - Roswell Park Cancer Institute, Buffalo, USA )
5 Dec 2013

Oncology organisations in India and bone health in prostate and breast cancer

Dr Hemant Malhotra - SMS Medical College Hospital, Jaipur, India
Oncology organisations in India and bone health in prostate and breast cancer ( Dr Hemant Malhotra - SMS Medical College Hospital, Jaipur, India )
5 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation